Beijing Saite Mingqiang Pharmaceutical Technology

Beijing Saite Mingqiang Pharmaceutical Technology

AI-driven small molecule drug discovery and development.

HQ location
Beijing, China
Launch date
Enterprise value
$55—83m
  • Edit
Notes (0)
More about Beijing Saite Mingqiang Pharmaceutical Technology
Made with AI
Edit

Beijing Saite Mingqiang Pharmaceutical Technology, also known as Scitech Pharma, is a company focused on the research and development of innovative small molecule drugs. Founded in 2015 and headquartered in Beijing, the company concentrates on therapeutic areas such as oncology, autoimmune diseases, and central nervous system disorders. The legal representative for the company is Wang Kexiu.

The company's business model is centered around its proprietary AI-driven drug design and screening platform, SigmaHIT®. This technology facilitates the discovery and optimization of small molecule drug candidates, moving them from conception through preclinical studies and into clinical evaluation. Scitech Pharma has established a significant research and development infrastructure, including a 20,000-square-meter base with 11 specialized laboratories for chemistry, biology, animal studies, and more. Their drug pipeline includes several in-house projects, with some candidates advancing to Phase I and Phase II clinical trials in China. The company has secured over 100 patents, with the majority being international.

Scitech Pharma operates as a privately held, venture capital-backed entity. It has successfully completed multiple funding rounds, including a Series A round in August 2022 and a later-stage venture round in April 2024, attracting investors like Zhizhong Investment, Elikon Venture, and Hangzhou Tigermed Consulting Company.

Keywords: small molecule drugs, drug discovery, AI drug design, oncology therapeutics, autoimmune diseases, central nervous system disorders, SigmaHIT, pharmaceutical R&D, clinical trials, drug development, biotechnology, life sciences, preclinical studies, venture capital-backed, cancer therapy, innovative drugs, pharmaceutical patents

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads